Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing. 

ten23 Expands Sterile Manufacturing Capacity at VIVA 1 Facility 

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market. 

Outsourcing Formulation Services for Biologics

There are many promising trials in the pipeline that may bring big news for major therapeutic areas.

Clinical Trials and their Impact on the Pharma Industry

Feliza Mirasol is the science editor for 

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing

Shriya Bhatkhande is a research associate at BioPlan Associates.

More than a third of CMOs are struggling to keep skilled technical and production staff.  

Staffing Shortages:  Major Hurdle for Bioprocess Contract Manufacturing Services in 2023

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

The more information shared, the smoother the approval process, says 
Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates. 

Sharing Critical Information for the Best Outcome

WuXi STA’s new high-potency injectable line has an annual capacity of 12 million units.

WuXi Sta Launches High Potency Manufacturing Line in Wuxi City Location

Podcasts

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Thermo Fisher Scientific’s new tumoroid culture medium kit is designed to help cancer researchers better model the disease.

Thermo Fisher Scientific Releases Tumoroid Culture Medium Kit 

Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.